A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer

Hum Gene Ther. 1998 Aug 10;9(12):1775-98. doi: 10.1089/hum.1998.9.12-1775.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus E1A Proteins / genetics*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Clinical Protocols
  • Female
  • Genetic Therapy*
  • Humans
  • Neoplasm Metastasis
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / therapy*
  • Receptor, ErbB-2 / genetics*

Substances

  • Adenovirus E1A Proteins
  • Receptor, ErbB-2